Corporate governance

Corporate governance

The board of directors is the company’s highest management and governing body. Implicit in our philosophy is the importance of establishing and complying with the best corporate governance policies. The mission of the board of directors is to act as a prudent guardian of shareholders’ interests and to oversee the management team. In order to fulfil its purposes with the utmost responsibility, the board of directors has established a number of control committees and regulations in line with legal requirements and corporate governance recommendations applicable to listed companies.

Composition of the board of directors and delegated committees

Miembros

de Torres Sanahuja, Santiago
Position
Executive Chairman

He holds a degree in Medicine and Surgery from the Autonomous University of Barcelona, is a Specialist in Clinical Pharmacology, and a Professor at the UAB.

 

He has been Chief Clinical Officer of the Hospital del Mar in Barcelona and has subsequently spent his career in important positions in the public sector: He has been director General of the National Plan on Drugs in the Ministry of Health, Undersecretary of the Ministry of Culture, Undersecretary of the Ministry of Social Affairs, and Senior Expert in the General Secretariat of the European Commission. He was also Delegate in Madrid of the Government of the Generalitat de Catalunya. His experience in the private sector has mainly been in the ICT, Health, and Renewable Energy sectors. He has been Vice-President of Terra Lycos, President of Eolia Tarraco, member of the Advisory Board of Indra, promoter of the Telemedicine company eDiagnostic, and member of the board of directors of Mémora

Santiago de Torres was re-elected as executive director on December 10, 2021 and his term of office runs until December 10, 2025.

 

 

Lozano Fernández, Isabel
Position
Chief Executive Officer

She holds a degree in Law and a master’s degree in Marketing. She has extensive experience in the management of biotechnology and oncology companies at a national and international level.

 

Before joining Atrys, she spent eight years as CEO of PharmaMar (a biopharmaceutical R+D+i company) and five years as CFO of the Zeltia Group.

Isabel Lozano was re-elected as executive director on December 10, 2021 and her term of office runs until December 10, 2025.

Echarri Torres, José Mª
Position
Proprietary Director

He holds a degree in Economics and Actuarial and Financial Sciences from the University of Barcelona, and a master’s degree in Financial Management from ESADE.

 

He was CFO of Oryzon Genomics, S.A. from 2003 to 2007.

He is currently CEO of Inveready Asset Management, S.G.E.C.R., S.A. and Chairman of Grupo Financiero Inveready, companies of which he has been a founding partner and major shareholder.

Member of the Board of Directors of more than 30 companies such as Masmóvil Ibercom, S.A., Agile Contents, S.A., Oryzon Genomics, S.A., Interiorvista, S.L., Palo Biofarma, S.L. or Grupo Natac, S.L.

He has actively participated in dozens of corporate transactions such as the sale of Passwordbank Technologies, S.L., the purchase of Pepephone by Masmóvil or the sale of Indisys, S.L. to Intel.

José Mª Echarri was elected as a proprietary director of Atrys on July 22, 2021 and re-elected as a proprietary director of Atrys, representing Inveready Convertible Finance Capital FCR, on December 10, 2021 and his term of office runs until December 10, 2025.

At the end of February 16, 2023, Jose Mª Echarri held 100 shares of Atrys Health, S.A.

de Lorenzo López, Fernando
Position
Proprietary Director
Appointments and remuneration committee
Member

He holds a degree in Law and a master’s degree from Instituto de Empresa.

 

General Secretary of Grupo Caser, where he also holds, among others, the position of Chairman of Caser Residencial S.A. and Chairman of the Board of Directors of Hospital Parque.

He was appointed director of Atrys on behalf of Grupo Caser on May 25, 2018.

Fernando de Lorenzo was re-elected as a proprietary director of Atrys, representing Grupo Caser, on June 25, 2018 and his term of office runs until May 25, 2024.

Baselga de la Vega, Antonio
Position
Proprietary Director

He holds a degree in Law from the Complutense University of Madrid and a master’s degree in Science from the University of Wales, Institute of Science and Technology (UWIST).

 

Chief Executive Officer and founding partner of Geniova Technologies, a dental company owned by the Swiss multinational Straumann Group.

From 1986 to 1992 he was Vice President of Bankers Trust Company Sucursal en España. From 1992 to 2008 he was founding partner and Managing Director of Bridgepoint Capital in Spain.

Since 2008 he dedicates part of his time to entrepreneurship, promoting and participating as an investor in several consumer companies and technology start-ups. He is also Senior Advisor at Avior, a 100% independent private equity firm focused on investing in Spanish companies.

Antonio Baselga was appointed proprietary director of Atrys, representing Onchena S.L., on October 17, 2019 and his term of office runs until October 17, 2025.

As of the close of February 16, 2023, Antonio Baselga de la Vega holds 7,000 shares of Atrys Health, S.A.

 

Guerrero Maldonado, Manuel
Position
Proprietary Director

Manuel Guerrero Maldonado holds a degree in Economics from the Complutense University of Madrid. He also holds an Executive MBA from the IESE Business School of the University of Navarra.

He has developed his professional career at Deutsche Bank, Barclays Bank (Head of the Restructuring Department), H.I.G. Capital (Director of Bayside Capital Iberia) and Ben Oldman Partners (Managing Director), in the areas of direction, analysis and management of investments, capital markets and debt.

He is currently Chief Investment Officer of Ion Ion.

He was appointed proprietary director of Atrys, representing Ion Ion S.L., by the board held on January 30, 2023, by co-optation procedure.

López Porta, Anabel
Position
Proprietary Director
Audit committee
Member

She holds a degree in Law from the University of Barcelona, a postgraduate degree in Labour Law, and a PDG (General Management Programme) qualification from IESE Business School.

 

She began her professional career at Grupo Godó in 1995, in the Sales, Finance and finally Controlling departments. Anabel López Porta joined Fersa Energías Renovables in 2004 as Assistant General Manager and participated in its IPO in May 2007. Throughout her career at Fersa she participated in the development of the portfolio of power generation projects as well as in the execution of the divestment plans of these projects, both nationally and internationally.

Appointed Chief Operating Officer in 2011, she was directly involved in all corporate operations of the company and assumed the General Management in July 2015, integrally managing the sale operation of the Fersa group that culminated in a takeover bid process by Audax Energía, S.A. Subsequently, in 2019, he participated directly in the reverse merger operation between Audax Energía and Fersa Energía Renovables, resulting in Grupo Audax Renovables, an independent energy group whose activities are focused on the production of 100% renewable energy, as well as the supply of 100% renewable electricity and gas.

He is currently a member of the board of directors and of the audit, nomination and remuneration committees of Audax Renovables. She is also a member of the board of directors of Ezentis and of its audit committee.

Anabel López was appointed proprietary director of Atrys, representing Excelsior Times S.L., on December 10, 2021 and her term of office runs until December 10, 2025.

González Sans, Maria Rosa
Position
Proprietary Director

She was a founding partner of Mediaworks, S.A., an advertising media centre, for 11 years, having formed part of the energy group Audax Energía since its inception in 2008.

 

Throughout her career, in the Audax group she has held positions of responsibility related to the areas of administration, finance and human resources, which has given her a transversal vision of the business. Since 2016 she led the development and expansion of the Audax group’s subsidiary in Italy where since 2018 she has also been a member of the Board.

Subsequently, in 2019 she participated directly in the reverse merger operation between Audax Energía and Fersa Energía Renovables, resulting in the Audax Renovables Group, an independent energy group whose activities focus on the production of 100% renewable energy, as well as the supply of 100% renewable electricity and gas.

She is currently a Corporate Director and Director of Audax Renovables.

Mª Rosa González was appointed proprietary director of Atrys, representing Excelsior Times S.L., on June 28, 2021 and was re-elected as proprietary director representing the same on December 10, 2021, and has a term of office until December 10, 2025.

Catá Sala, Aurora
Position
Independent Director
Appointments and remuneration committee
President

She holds a degree in industrial engineering from the Polytechnic University of Catalonia (UPC), and an MBA from IESE Business School.

 

After starting her career at Bank of America in the late 1980s, she joined Nissan in 1991 and spent five years as its Chief Financial Officer. In 1996, she became General Manager of Radio Televisión Española (RTVE) and in 1999 she was appointed CEO of Grupo Planeta 2010. In 2008 she became Partner of the headhunting firm Seeliger y Conde, and maintained that role until 2020.

She has combined her roles in these and other organizations with her work as an independent director in companies such as Atresmedia (2009-2021), Repsol (2021) or Banco Sabadell (2015), and in the last two, respectively, she is a member of the appointments and remuneration committees and chairs the remuneration committee. She has also been a director of Instituto Catalán de Finanzas, Abantia and Service Point, among other companies.

Aurora Catá has also chaired Barcelona Global since 2020 and is also a trustee of the Cellnex Foundation.

Aurora Catá was appointed independent director of Atrys on November 4, 2021 and was re-elected on December 10, 2021, and her term of office runs until December 10, 2025.

As of the close of business on February 16, 2023, Aurora Catá holds 15,789 shares of Atrys Health, S.A.

Cano Fernández, Jaime
Position
Independent Director
Audit committee
President
Comisión de nombramientos y retribuciones
Member

He holds a degree in Law from the University of Cantabria and has taken several courses at IESE and the New York Institute of Finance.

 

He served as director of internal audit for the Banco Santander group in the United States. He was manager of the same Bank in Bolivia, director with investors, analysts and investors in New York and executive vice president in Colombia until 2005.

Member since 2015 of the advisory board for LatAm of Howden, advisor to BNP Cardif Mexico, and advisor to El Corte Inglés among others. He is managing partner of Negozia S.A. and Senior Advisor at Coltefinanciera and PMGroup.

Jaime Cano was elected independent director of Atrys on June 24, 2016 and re-elected independent director of Atrys on June 28, 2022, and his term of office runs until June 28, 2026.

As of May 30, 2023, Jaime Cano holds 25,000 shares of Atrys Health, S.A.

del Barrio Seoane, Jaime
Position
Independent Director
Audit committee
Member
Appointments and remuneration committee
Member

He holds a degree in Medicine from the University of Cantabria, and is a specialist in Internal Medicine.

 

He has been an assistant physician at the Marqués de Valdecilla University Hospital.

In 1995, and for two full legislatures, he was responsible for implementing the Regional Plan on Drugs in Cantabria and Minister of Health and Social Services of the Government of Cantabria.

For 11 years he has directed Roche Institute and in 2015 he joined as Senior Advisor at EY (formerly Ernst & Young). He is an independent director at E-Health Technical Solutions. He was also an independent director at NIMgenetics.

Jaime del Barrio was elected independent director on May 24, 2016 and was re-elected independent director on June 28, 2022 and his term of office runs until June 28, 2026. Jaime del Barrio is also a coordinating director.

González Durántez, Miriam
Position
Independent Director

She holds a degree in Law from the University of Valladolid and a Master’s degree in European Politics from the College of Bruges and was Senior Associate at St Antony’s College, Oxford.

 

She began her career holding various positions in the institutional field as an advisor in commercial law and economic relations for the European Union and the British Government. Subsequently, Miriam worked as a partner in several renowned international law firms such as DLA Piper and Dechert LLP. She has also held relevant positions on the boards of national and international listed companies, becoming a director of Acciona; Chair of the Audit and Remuneration Committees of UBS Limited in the UK; Chair of the Audit and Risk Committees of UBS Spain and and Vice-Chair of UBS ESE. She has been an adjunct professor at Stanford University. Miriam is currently founder of España Mejor, Inspiring Girls and Altius (an Africa-focused law firm), a member of the panel of international trade arbitrators of the European Union and a member of the Diversity Council of Toyota Europe, among others.

Miriam González was elected independent director of Atrys on June 28, 2023.

Castañeda González, Alberto
Position
Non-director Secretary
Audit committee
Non-director Secretary
Appointments and remuneration committee
Non-director Secretary

He holds a degree in Law from the Complutense University of Madrid, 1995. LL.M. from Leibniz University Hannover (Germany), 1996; Advanced Programme in
Telecommunications, Media and Information Technology Law, Instituto de Empresa, 2001; American Law Programme, Columbia University, New York, 2009. 

 

Founding partner of Castañeda Abogados (2002). Secretary of the Board of Directors of numerous companies belonging to Spanish and international groups, including Masmovil Ibercom, the fourth largest telecommunications operator in Spain, Xfera Consumer Finance EFC, Kreab Iberia or Minerals Technologies, he has more than 25 years of experience in advising in the field of corporate law.

Alberto Castañeda was appointed non-director secretary on May 17, 2018.

Camuñas Caruana, Gabriela
Position
Non-director vice-Secretary
Audit committee
Non-director vice-Secretary
Appointments and remuneration committee
Non-director vice-Secretary

She holds a degree in Law and Business Administration and Management (ADE) from the Universidad Pontificia de Comillas (ICADE E-3). She holds a master’s degree in International Legal Studies (LL.M) from Georgetown University (Washington DC).

 

Gabriela is the legal head of the entire Atrys Group. Prior to joining Atrys, she worked in different national and international law firms (Cuatrecasas, Linklaters and Pinsent Masons) specializing in corporate and M&A law.

She joined Atrys in September 2020 and was appointed vice-secretary non-counselor on October 27, 2020.

Corporate Governance Documents

Articles of Association of Atrys Health S.A.

SEE PDF

Regulations of the General Shareholders’ Meeting

SEE PDF

Regulations of the Board of Directors

SEE PDF

Regulations in the field of the Securities Market

SEE PDF

Remuneration Policy for Directors 2022, 2023, and 2024 (as amended by the GSM of 28th June 2022 and 20 december 2022)

SEE PDF

Protocol for approval, reporting and periodic monitoring of related-party transaction

SEE PDF

Policy for communication and contacts with shareholders, institutional investors and proxy advisors

SEE PDF

General Meetings and information for shareholder

2023

Extraordinary General Shareholders’ Meeting December 21, 2023

Announcement of call for tenders

SEE PDF

Number of shares and voting rights

SEE PDF

Full text of the proposed resolutions to be submitted for approval at the General Shareholders’ Meeting

SEE PDF

Report of the Board of Directors on the proposal for the amendment of the by-laws

SEE PDF

Report of the Board of Directors on the delegation of powers to the Board of Directors to issue bonds or other fixed-income securities convertible or non-convertible into shares, with express delegation of the power to exclude the pre-emptive right

SEE PDF

Attendance, proxy and remote voting card template

SEE PDF

Rules and information on how the shareholder can exercise his right to information

SEE PDF
Access to the electronic voting and proxy platform
Attendance, proxy and remote voting procedures
SEE PDF
Access to the electronic forum
Rules of operation of the electronic shareholder forum
SEE PDF

Ordinary General Shareholders’ Meeting June 28, 2023

Announcement of call for tenders

SEE PDF

Number of shares and voting rights

SEE PDF

Full text of the proposed resolutions to be submitted for approval at the General Shareholders’ Meeting

SEE PDF

Individual financial statements and individual management report for 2022, together with the auditor’s report.

SEE PDF

Consolidated financial statements and consolidated management report for the 2022 financial year, together with the auditor’s report and the Statement of Non-Financial Information

SEE PDF

Annual Corporate Governance Report for year 2022

SEE PDF

Report issued by the Audit Committee on the auditor’s independence in fiscal year 2022

SEE PDF

Reports of the Board of Directors and the Nomination and Compensation Committee on the election of Manuel Guerrero Maldonado as proprietary director

SEE PDF

Reports of the Board of Directors and the Nomination and Compensation Committee on the election of Miryan González Durántez as independent director

SEE PDF

Reports of the Board of Directors and the Nomination and Compensation Committee on the modification of the Directors’ Remuneration Policy and the consolidated text of the new Policy

SEE PDF

Annual Report on Directors’ Remuneration for the year 2022

SEE PDF

Attendance, proxy and remote voting card template

SEE PDF

Rules and information on how the shareholder can exercise his right to information

SEE PDF

Report on the activities and operation of the Audit and Control Committee for the fiscal year 2022

SEE PDF

Report on the activities and operation of the Nominating and Compensation Committee for fiscal year 2022

SEE PDF

Report of the Audit and Control Committee on related-party transactions for fiscal year 2022

SEE PDF
Access to the electronic voting and proxy platform
Attendance, proxy and remote voting procedures
SEE PDF
Access to the electronic forum
Rules of operation of the electronic shareholder forum
SEE PDF

2022

Extraordinary General Shareholders’ Meeting March 11, 2022

Announcement of call for tenders

SEE PDF

Number of shares and voting rights

SEE PDF

Full text of the proposed resolutions to be submitted for approval at the General Shareholders’ Meeting

SEE PDF

Report of the Board of Directors on the proposed capital increase by offsetting claims

SEE PDF

Certification of the auditor of the company’s accounts ex 301 of the LSC

SEE PDF

The attendance, proxy and remote voting card model

SEE PDF

Rules and information on the means and procedures for granting proxies at the General Shareholders’ Meeting and remote voting

SEE PDF

Rules and information on how the shareholder can exercise his right to information

SEE PDF
Access to the electronic voting and proxy platform
Attendance, proxy and remote voting procedures
SEE PDF
Access to the electronic forum
Rules of operation of the electronic shareholder forum
SEE PDF

Ordinary General Shareholders’ Meeting June 28, 2022

Announcement of call for tenders

SEE PDF

Number of shares and voting rights

SEE PDF

Full text of the proposed resolutions to be submitted for approval at the General Shareholders’ Meeting

SEE PDF

Individual financial statements and individual management report for 2021, together with the auditor’s report.

SEE PDF

Consolidated financial statements and consolidated management report for the 2021 financial year, together with the auditor’s report

SEE PDF

Consolidated Statement of Non-Financial Information for fiscal year 2021, together with the independent auditors’ report

SEE PDF

Statement of the Board’s responsibility for the contents of the annual accounts (individual and consolidated)

SEE PDF

Annual Corporate Governance Report for fiscal year 2021

SEE PDF

Report issued by the Audit Committee on the auditor’s independence in fiscal year 2021

SEE PDF

Reports of the Board of Directors and the Nomination and Compensation Committee on the re-election of Jaime del Barrio and Jaime Cano as independent directors.

SEE PDF

Directors’ Remuneration Policy proposed by the Board of Directors and report of the Appointments and Remuneration Committee on its modification.

SEE PDF

Annual Report on Directors’ Remuneration for the year 2021

SEE PDF

Report of the Board of Directors in connection with the authorization to the Board of Directors to increase the capital stock pursuant to articles 297.1.b) and 506 of the LSC.

SEE PDF

Attendance, proxy and remote voting card template

SEE PDF

Rules and information on how the shareholder can exercise his right to information

SEE PDF

Report on the activities and operation of the Audit and Control Committee for the fiscal year 2021

SEE PDF

Report on the activities and operation of the Nominating and Compensation Committee for fiscal year 2021

SEE PDF

The Report of the Audit and Control Committee on related-party transactions for fiscal year 2021

SEE PDF
Access to the electronic voting and proxy platform
Attendance, proxy and remote voting procedures
SEE PDF
Access to the electronic forum
Rules of operation of the electronic shareholder forum
SEE PDF

Extraordinary General Shareholders’ Meeting December 20, 2022

Announcement of call for tenders

SEE PDF

Number of shares and voting rights

SEE PDF

Full text of the proposed resolutions to be submitted for approval at the General Shareholders’ Meeting

SEE PDF

Report of the Board of Directors on the proposed capital increase by offsetting claims

SEE PDF

Certification of the auditor of the company’s accounts ex 301 of the LSC

SEE PDF

Report of the Appointments and Remuneration Committee on the modification of the Directors’ Remuneration Policy and revised text of the Policy

SEE PDF

Report of the Board of Directors on the proposed capital increase by monetary contributions excluding preemptive subscription rights approved by the Board of Directors on June 8, 2022 ex article 506.4 of the LSC.

SEE PDF

Attendance, proxy and remote voting card template

SEE PDF

Rules and information on how the shareholder can exercise his right to information

SEE PDF
Access to the electronic voting and proxy platform
Attendance, proxy and remote voting procedures
SEE PDF
Access to the electronic forum
Rules of operation of the electronic shareholder forum
SEE PDF

2021

Merger project between Instituto de Estudios Celulares y Moleculares I.C.M S.A.U. and Atrys Health S.A.

Atrys-ICM merger plan

SEE PDF

Announcement of the Atrys-ICM Merger

SEE PDF

Atrys CDA Merger Agreements

SEE PDF

Bylaws of Atrys and ICM

SEE PDF

Atrys Balance Sheets 2018-2020

SEE PDF

MSI Balance Sheets 2018-2020

SEE PDF

Atrys and ICM directors’ identification data

SEE PDF

Extraordinary General Shareholders’ Meeting on March 25, 2021.

Notice of the Extraordinary General Shareholders’ Meeting

SEE PDF

Full texts of the motions for resolutions

SEE PDF

Report issued by the Board of Directors and BDO’s certification in connection with the capital increase by offsetting of receivables

SEE PDF

Reports issued by the Board of Directors and Mazars, as independent expert, in connection with the capital increase by means of non-cash contribution

SEE PDF

Current bylaws

SEE PDF

Rules and Regulations of the General Shareholders’ Meeting. (see PDF)

SEE PDF

Ordinary General Shareholders’ Meeting held on June 24, 2021

Convening of the meeting

SEE PDF

Full texts of the motions for resolutions

SEE PDF

Consolidated and individual financial statements and consolidated and individual management report for the 2020 financial year, together with the auditor’s report

SEE PDF

Report issued by the Audit Committee on the auditor’s independence in fiscal year 2020

SEE PDF

Report issued by the board of directors on the proposed capital increase by offsetting credits together with the auditor’s certification.

SEE PDF

Reports of the Board of Directors and the Appointments and Remuneration Committee on the appointment of Ms. Anabel López Porta, Ms. María Rosa González Sans and Mr. Óscar Santos Juvé as new Board Members.

SEE PDF

Current bylaws

SEE PDF

Regulations of the General Shareholders’ Meeting in force

SEE PDF

Extraordinary General Stockholders’ Meeting December 10, 2021

Agenda for the General Shareholders’ Meeting on December 10, 2021.

SEE PDF

2020

Junta General Ordinaria de Accionistas del 17 de julio de 2020

Convening of the meeting

SEE PDF

Full texts of the motions for resolutions

SEE PDF

Individual financial statements, individual management report and auditors’ report for the fiscal year 2019.

SEE PDF

Consolidated financial statements, consolidated management report and auditors’ report for the year 2019

SEE PDF

Report issued by the Audit Committee on the independence of the auditor for the 2019 fiscal year.

SEE PDF

Report issued by the board of directors on the proposed capital increase, together with the report of the independent expert (Grant Thornton, S.L.P.)

SEE PDF

Report issued by the board of directors on the proposed issue of convertible debentures, together with the report of the independent expert (Grant Thornton, S.L.P.)

SEE PDF

Report issued by the Board of Directors on the proposed amendment of article 10.3 of the Bylaws

SEE PDF

Report issued by the Board of Directors on the proposed inclusion of a new Article 11 bis of the Regulations of the General Shareholders’ Meeting.

SEE PDF

Current Associati articles

SEE PDF

Regulations of the General Shareholders’ Meeting in force

SEE PDF

Extraordinary General Shareholders’ Meeting of December 21, 2020

Notice of the Extraordinary General Shareholders’ Meeting

SEE PDF

Full texts of the motions for resolutions

SEE PDF

Report issued by the Board of Directors and BDO’s certification in connection with the capital increase by offsetting of receivables

SEE PDF

Report issued by the Board of Directors in connection with the proposed delegation of powers to the Board to increase the capital stock

SEE PDF

Current bylaws

SEE PDF

Current Rules and Regulations of the General Shareholders’ Meeting

SEE PDF

2019

Ordinary General Shareholders’ Meeting to be held on May 31, 2019

Notice of the Ordinary General Shareholders’ Meeting to be held on May 31, 2019.

SEE PDF

Resolutions adopted at the Ordinary General Shareholders’ Meeting of May 31, 2019.

SEE PDF

Extraordinary General Shareholders’ Meeting to be held on October 17, 2019.

Notice of the Extraordinary General Shareholders’ Meeting to be held on October 17, 2019.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting held on October 17, 2019.

SEE PDF

Extraordinary General Shareholders’ Meeting on December 17, 2019

Notice of the Extraordinary General Shareholders’ Meeting to be held on December 17, 2019.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting held on October 17, 2019.

SEE PDF

2018

Ordinary General Shareholders’ Meeting held on May 25, 2018.

Notice of the Extraordinary General Shareholders’ Meeting to be held on May 25, 2018.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting held on December 22, 2017.

SEE PDF

Extraordinary General Shareholders’ Meeting of December 22, 2017.

Notice of the Extraordinary General Shareholders’ Meeting of December 22, 2017.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting of December 19, 2018.

SEE PDF

2017

Ordinary General Shareholders’ Meeting held on May 27, 2017.

Notice of the Extraordinary General Shareholders’ Meeting to be held on June 27, 2017.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting held on June 27, 2017.

SEE PDF

Extraordinary General Shareholders’ Meeting of December 19, 2017.

Notice of the Extraordinary General Shareholders’ Meeting of December 19, 2018.

SEE PDF

Resolutions adopted at the Extraordinary General Shareholders’ Meeting held on December 22, 2017.

SEE PDF

Capital Increase Documentation and Prospectuses

Report of the Board of Directors in connection with the issue of contingent convertible bonds with the exclusion of preemptive subscription rights (27/12/2023)

SEE PDF

Report of the Board of Directors in connection with the capital increase by monetary contribution with the exclusion of preemptive subscription rights (12/27/2022)

SEE PDF

Report of the Board of Directors in connection with the capital increase via Accelerated Bookbuild Offering (08/06/2022)

SEE PDF

Independent expert’s report on exclusion of pre-emptive subscription rights in connection with the capital increase via Accelerated Bookbuild Offering (08/06/2022)

SEE PDF

Atrys Health S.A. Registration Document. (03/02/2022)

SEE PDF

Securities Note on the admission to trading of the shares of Atrys Health, S.A. on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through the Spanish Stock Exchange Interconnection System (SIBE). (03/02/2022)

SEE PDF

Capital Increase Document (CRD) March 2021

SEE PDF

Capital Increase Document (CRD) July 2020

SEE PDF

Capital Increase Document (CAD) October 2019

SEE PDF

Capital Increase Document (CRD) December 2017

SEE PDF

MAB Listing Information Document (DIIM) June 2016

SEE PDF

General Bondholders’ Meeting

Bondholders’ Meeting

Notice and Agenda of the Bondholders’ Meeting of the Convertible Bond on 13 December 2021

SEE PDF

Notice and Agenda of the Bondholders’ Meeting of the MARF Bond Programme on 13 December 2021

SEE PDF

Notice and Agenda of the Bondholders’ Meeting of the Convertible Bond on 16 February 2021

SEE PDF

Notice and Agenda of the Bondholders’ Meeting of the MARF Bond Programme on 16 February 2021

SEE PDF

Bond Issues Documentation

Basic Informative Document of Incorporation of Medium and Long Term Securities to the Alternative Fixed-Income Market (MARF) of July 2020

SEE PDF